New Drug Pricing Policy Empowers Innovation; Overseas Licensing Accelerates Dual-Drive Mechanism for the IndustryWallstreetcn·Apr 16, 2026 at 10:59 PMABBV+0.43%002653-2.89%
Central and Eastern Europe Fund's Glen increased its holdings in Haisco and Pharmaron in the third quarter, but strong performance still fails to prevent net redemptionsWallstreetcn·Oct 28, 2025 at 01:56 PM300759+0.21%03759+0.15%
Pharmaceutical and medical stocks continue to strengthen, with FENGYUAN PHARMACEUTICAL hitting the limit up, Hengrui Pharma rising over 7%, and Haisco, BIOCAUSE HEILEN PHARMA, Yatai pharm, and Yirui Biologics also following suitWallstreetcn·Jul 28, 2025 at 01:37 AM002653-2.89%301211-1.10%
A-shares closing: The Shanghai Composite Index fluctuated narrowly and slightly rose, with the new consumption concept exploding againWallstreetcn·Jun 12, 2025 at 07:02 AM002878+2.40%002237-1.73%
